Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SGD vs LGND vs PRGO vs GREE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SGD
Safe and Green Development Corporation

Real Estate - Development

Real EstateNASDAQ • US
Market Cap$155K
5Y Perf.-99.4%
LGND
Ligand Pharmaceuticals Incorporated

Biotechnology

HealthcareNASDAQ • US
Market Cap$4.13B
5Y Perf.+220.6%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-55.5%
GREE
Greenidge Generation Holdings Inc.

Financial - Capital Markets

Financial ServicesNASDAQ • US
Market Cap$19M
5Y Perf.-68.5%

SGD vs LGND vs PRGO vs GREE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SGD logoSGD
LGND logoLGND
PRGO logoPRGO
GREE logoGREE
IndustryReal Estate - DevelopmentBiotechnologyDrug Manufacturers - Specialty & GenericFinancial - Capital Markets
Market Cap$155K$4.13B$1.61B$19M
Revenue (TTM)$5M$251M$4.18B$60M
Net Income (TTM)$-14M$49M$-1.82B$-2M
Gross Margin16.6%85.9%34.2%79.7%
Operating Margin-186.2%7.0%-4.1%-19.2%
Forward P/E24.6x5.5x
Total Debt$10M$7M$3.97B$68M
Cash & Equiv.$296K$72M$532M$9M

SGD vs LGND vs PRGO vs GREELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SGD
LGND
PRGO
GREE
StockSep 23Feb 26Return
Safe and Green Deve… (SGD)1000.6-99.4%
Ligand Pharmaceutic… (LGND)100320.6+220.6%
Perrigo Company plc (PRGO)10044.5-55.5%
Greenidge Generatio… (GREE)10031.5-68.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: SGD vs LGND vs PRGO vs GREE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LGND leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. SGD also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
SGD
Safe and Green Development Corporation
The Real Estate Income Play

SGD is the clearest fit if your priority is growth.

  • 27.7% FFO/revenue growth vs GREE's -15.4%
Best for: growth
LGND
Ligand Pharmaceuticals Incorporated
The Growth Play

LGND carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 27.3%, EPS growth -107.5%, 3Y rev CAGR -11.6%
  • 73.0% 10Y total return vs GREE's -62.9%
  • Lower volatility, beta 0.99, Low D/E 0.9%, current ratio 8.93x
  • Beta 0.99, current ratio 8.93x
Best for: growth exposure and long-term compounding
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Better valuation composite
  • 9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Best for: income & stability
GREE
Greenidge Generation Holdings Inc.
The Financial Play

GREE lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: financial services exposure
See the full category breakdown
CategoryWinnerWhy
GrowthSGD logoSGD27.7% FFO/revenue growth vs GREE's -15.4%
ValuePRGO logoPRGOBetter valuation composite
Quality / MarginsLGND logoLGND19.3% margin vs SGD's -277.3%
Stability / SafetyLGND logoLGNDBeta 0.99 vs GREE's 3.33
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)LGND logoLGND+99.1% vs SGD's -80.4%
Efficiency (ROA)LGND logoLGND3.3% ROA vs SGD's -35.9%, ROIC -2.3% vs -50.6%

SGD vs LGND vs PRGO vs GREE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SGDSafe and Green Development Corporation

Segment breakdown not available.

LGNDLigand Pharmaceuticals Incorporated
FY 2024
Royalty
27.9%$109M
Intangible Royalty Assets
24.4%$95M
Royalty, Kyprolis
9.8%$38M
Material Sales, Captisol, Core
7.9%$31M
Material Sales, Captisol
7.9%$31M
Contract Revenue
7.0%$27M
Service
6.5%$26M
Other (4)
8.5%$33M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B
GREEGreenidge Generation Holdings Inc.
FY 2024
Cryptocurrency Mining
64.2%$19M
Power And Capacity
35.8%$11M

SGD vs LGND vs PRGO vs GREE — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLGNDLAGGINGGREE

Income & Cash Flow (Last 12 Months)

LGND leads this category, winning 5 of 6 comparable metrics.

PRGO is the larger business by revenue, generating $4.2B annually — 840.6x SGD's $5M. LGND is the more profitable business, keeping 19.3% of every revenue dollar as net income compared to SGD's -2.8%. On growth, SGD holds the edge at +42.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSGD logoSGDSafe and Green De…LGND logoLGNDLigand Pharmaceut…PRGO logoPRGOPerrigo Company p…GREE logoGREEGreenidge Generat…
RevenueTrailing 12 months$5M$251M$4.2B$60M
EBITDAEarnings before interest/tax-$9M$52M$58M$4M
Net IncomeAfter-tax profit-$14M$49M-$1.8B-$2M
Free Cash FlowCash after capex-$3M$31M$108M-$20M
Gross MarginGross profit ÷ Revenue+16.6%+85.9%+34.2%+79.7%
Operating MarginEBIT ÷ Revenue-186.2%+7.0%-4.1%-19.2%
Net MarginNet income ÷ Revenue-2.8%+19.3%-43.5%-33.2%
FCF MarginFCF ÷ Revenue-52.9%+12.2%+2.6%-37.7%
Rev. Growth (YoY)Latest quarter vs prior year+42.3%+122.8%-7.2%
EPS Growth (YoY)Latest quarter vs prior year+57.1%+15.6%-56.4%+2.3%
LGND leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 3 of 6 comparable metrics.

On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than LGND's 322.1x.

MetricSGD logoSGDSafe and Green De…LGND logoLGNDLigand Pharmaceut…PRGO logoPRGOPerrigo Company p…GREE logoGREEGreenidge Generat…
Market CapShares × price$155,445$4.1B$1.6B$19M
Enterprise ValueMkt cap + debt − cash$10M$4.1B$5.1B$79M
Trailing P/EPrice ÷ TTM EPS-0.02x-956.05x-1.14x-0.65x
Forward P/EPrice ÷ next-FY EPS est.24.64x5.53x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple322.10x7.42x38.86x
Price / SalesMarket cap ÷ Revenue0.75x24.74x0.38x0.32x
Price / BookPrice ÷ Book value/share0.18x4.63x0.55x
Price / FCFMarket cap ÷ FCF53.41x11.12x
PRGO leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

LGND leads this category, winning 7 of 9 comparable metrics.

LGND delivers a 5.1% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-7 for SGD. LGND carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to SGD's 11.95x. On the Piotroski fundamental quality scale (0–9), SGD scores 5/9 vs GREE's 3/9, reflecting solid financial health.

MetricSGD logoSGDSafe and Green De…LGND logoLGNDLigand Pharmaceut…PRGO logoPRGOPerrigo Company p…GREE logoGREEGreenidge Generat…
ROE (TTM)Return on equity-7.0%+5.1%-50.7%
ROA (TTM)Return on assets-35.9%+3.3%-19.8%-3.2%
ROICReturn on invested capital-50.6%-2.3%+3.7%-57.2%
ROCEReturn on capital employed-3.1%-2.7%+4.3%-23.9%
Piotroski ScoreFundamental quality 0–95543
Debt / EquityFinancial leverage11.95x0.01x1.35x
Net DebtTotal debt minus cash$10M-$65M$3.4B$59M
Cash & Equiv.Liquid assets$296,202$72M$532M$9M
Total DebtShort + long-term debt$10M$7M$4.0B$68M
Interest CoverageEBIT ÷ Interest expense-1.89x22.69x-7.20x0.70x
LGND leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LGND leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in LGND five years ago would be worth $16,102 today (with dividends reinvested), compared to $13 for SGD. Over the past 12 months, LGND leads with a +99.1% total return vs SGD's -80.4%. The 3-year compound annual growth rate (CAGR) favors LGND at 39.5% vs SGD's -89.1% — a key indicator of consistent wealth creation.

MetricSGD logoSGDSafe and Green De…LGND logoLGNDLigand Pharmaceut…PRGO logoPRGOPerrigo Company p…GREE logoGREEGreenidge Generat…
YTD ReturnYear-to-date-14.9%+10.6%-13.5%-25.6%
1-Year ReturnPast 12 months-80.4%+99.1%-51.2%+29.0%
3-Year ReturnCumulative with dividends-99.9%+171.6%-58.1%-71.0%
5-Year ReturnCumulative with dividends-99.9%+61.0%-60.1%-99.2%
10-Year ReturnCumulative with dividends-99.9%+73.0%-77.7%-62.9%
CAGR (3Y)Annualised 3-year return-89.1%+39.5%-25.2%-33.8%
LGND leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

LGND leads this category, winning 2 of 2 comparable metrics.

LGND is the less volatile stock with a 0.99 beta — it tends to amplify market swings less than GREE's 3.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LGND currently trades 85.0% from its 52-week high vs SGD's 6.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSGD logoSGDSafe and Green De…LGND logoLGNDLigand Pharmaceut…PRGO logoPRGOPerrigo Company p…GREE logoGREEGreenidge Generat…
Beta (5Y)Sensitivity to S&P 5001.57x1.03x1.21x3.37x
52-Week HighHighest price in past year$2.36$247.38$28.44$2.42
52-Week LowLowest price in past year$0.11$98.89$9.23$0.87
% of 52W HighCurrent price vs 52-week peak+6.9%+85.0%+41.2%+50.4%
RSI (14)Momentum oscillator 0–10040.059.360.952.9
Avg Volume (50D)Average daily shares traded0226K3.4M138K
LGND leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: LGND as "Buy", PRGO as "Hold". Consensus price targets imply 208.9% upside for PRGO (target: $36) vs 27.3% for LGND (target: $268). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricSGD logoSGDSafe and Green De…LGND logoLGNDLigand Pharmaceut…PRGO logoPRGOPerrigo Company p…GREE logoGREEGreenidge Generat…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$267.75$36.20
# AnalystsCovering analysts1736
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises110
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

LGND leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallLigand Pharmaceuticals Inco… (LGND)Leads 4 of 6 categories
Loading custom metrics...

SGD vs LGND vs PRGO vs GREE: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is SGD or LGND or PRGO or GREE a better buy right now?

For growth investors, Ligand Pharmaceuticals Incorporated (LGND) is the stronger pick with 27.

3% revenue growth year-over-year, versus -15. 4% for Greenidge Generation Holdings Inc. (GREE). Analysts rate Ligand Pharmaceuticals Incorporated (LGND) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SGD or LGND or PRGO or GREE?

Over the past 5 years, Ligand Pharmaceuticals Incorporated (LGND) delivered a total return of +61.

0%, compared to -99. 9% for Safe and Green Development Corporation (SGD). Over 10 years, the gap is even starker: LGND returned +82. 2% versus SGD's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SGD or LGND or PRGO or GREE?

By beta (market sensitivity over 5 years), Ligand Pharmaceuticals Incorporated (LGND) is the lower-risk stock at 1.

03β versus Greenidge Generation Holdings Inc. 's 3. 37β — meaning GREE is approximately 228% more volatile than LGND relative to the S&P 500. On balance sheet safety, Ligand Pharmaceuticals Incorporated (LGND) carries a lower debt/equity ratio of 1% versus 12% for Safe and Green Development Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — SGD or LGND or PRGO or GREE?

By revenue growth (latest reported year), Ligand Pharmaceuticals Incorporated (LGND) is pulling ahead at 27.

3% versus -15. 4% for Greenidge Generation Holdings Inc. (GREE). On earnings-per-share growth, the picture is similar: Greenidge Generation Holdings Inc. grew EPS 57. 6% year-over-year, compared to -21. 2% for Safe and Green Development Corporation. Over a 3-year CAGR, PRGO leads at -1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SGD or LGND or PRGO or GREE?

Ligand Pharmaceuticals Incorporated (LGND) is the more profitable company, earning -2.

4% net margin versus -42. 9% for Safe and Green Development Corporation — meaning it keeps -2. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -31. 6% for SGD. At the gross margin level — before operating expenses — LGND leads at 93. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is SGD or LGND or PRGO or GREE more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

5x forward P/E versus 24. 6x for Ligand Pharmaceuticals Incorporated — 19. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 208. 9% to $36. 20.

07

Which pays a better dividend — SGD or LGND or PRGO or GREE?

In this comparison, PRGO (9.

8% yield) pays a dividend. SGD, LGND, GREE do not pay a meaningful dividend and should not be held primarily for income.

08

Is SGD or LGND or PRGO or GREE better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

21), 9. 8% yield). Greenidge Generation Holdings Inc. (GREE) carries a higher beta of 3. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRGO: -77. 7%, GREE: -62. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between SGD and LGND and PRGO and GREE?

These companies operate in different sectors (SGD (Real Estate) and LGND (Healthcare) and PRGO (Healthcare) and GREE (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SGD is a small-cap quality compounder stock; LGND is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock; GREE is a small-cap quality compounder stock. PRGO pays a dividend while SGD, LGND, GREE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SGD

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $20B
  • Revenue Growth > 2114%
Run This Screen
Stocks Like

LGND

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 61%
  • Net Margin > 11%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Stocks Like

GREE

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 47%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SGD and LGND and PRGO and GREE on the metrics below

Revenue Growth>
%
(SGD: 4229.2% · LGND: 122.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.